Literature DB >> 30193792

Endothelial function is disturbed in a hypertensive diabetic animal model of HFpEF: Moderate continuous vs. high intensity interval training.

Zelia Schmederer1, Natale Rolim2, T Scott Bowen3, Axel Linke4, Ulrik Wisloff5, Volker Adams6.   

Abstract

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) is associated with endothelial dysfunction, but the molecular mechanisms still remain unclear. Whether exercise training (ET) along with which optimal modality can improve endothelial function is controversial. The present study used a hypertensive, diabetic-driven HFpEF animal model (ZSF1 rats) to determine whether different training modalities (moderate-continuous (MCT) and high-intensity interval training (HIIT)) could reverse endothelial dysfunction and to understand the underlying molecular mechanisms. METHODS AND
RESULTS: The development of HFpEF in ZSF1 obese animals was confirmed by echocardiography and hemodynamic measurements. Thereafter, animals were randomized into following groups: 1) sedentary, 2) 8 weeks of MCT, 3) 8 weeks of HIIT. ZSF1 lean animals served as control. In vitro measurement of endothelial function in aortic rings revealed significantly impaired endothelial-dependent and -independent vasodilation in HFpEF, which was reversed by MCT and HIIT. At the molecular level, the development of endothelial dysfunction was associated with a reduced expression / activation of endothelial nitric oxide synthase (eNOS), an increase in NADPH and activation of c-Jun N-terminal protein kinase (JNK), a reduced collagen I/III ratio and a reduced lining of the vessel wall by endothelial cells. ET primarily decreased NADPH oxidase expression, and JNK activation, elevated collagen I/III ratio while further improving aortic endothelial cell coverage.
CONCLUSIONS: The present study provides evidence that endothelial dysfunction occurs in experimental HFpEF and that ET, independent of the studied training modality, reverses endothelial dysfunction and specific molecular alterations. ET may therefore provide an important therapeutic intervention for HFpEF patients.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30193792     DOI: 10.1016/j.ijcard.2018.08.087

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  18 in total

1.  Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.

Authors:  Stephan Mueller; Ephraim B Winzer; André Duvinage; Andreas B Gevaert; Frank Edelmann; Bernhard Haller; Elisabeth Pieske-Kraigher; Paul Beckers; Anna Bobenko; Jennifer Hommel; Caroline M Van de Heyning; Katrin Esefeld; Pia von Korn; Jeffrey W Christle; Mark J Haykowsky; Axel Linke; Ulrik Wisløff; Volker Adams; Burkert Pieske; Emeline M van Craenenbroeck; Martin Halle
Journal:  JAMA       Date:  2021-02-09       Impact factor: 56.272

Review 2.  Guidelines for animal exercise and training protocols for cardiovascular studies.

Authors:  David C Poole; Steven W Copp; Trenton D Colburn; Jesse C Craig; David L Allen; Michael Sturek; Donal S O'Leary; Irving H Zucker; Timothy I Musch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-20       Impact factor: 4.733

Review 3.  Heart Failure with Preserved Ejection Fraction: Pathogenesis, Diagnosis, Exercise, and Medical Therapies.

Authors:  Qingyi Zhan; Wenjing Peng; Siqi Wang; Juan Gao
Journal:  J Cardiovasc Transl Res       Date:  2022-09-28       Impact factor: 3.216

Review 4.  High-density lipoprotein-mediated cardioprotection in heart failure.

Authors:  Ampadu O Jackson; Jun Meng; Huifang Tang; Kai Yin
Journal:  Heart Fail Rev       Date:  2021-07       Impact factor: 4.214

Review 5.  Beyond the myocardium? SGLT2 inhibitors target peripheral components of reduced oxygen flux in the diabetic patient with heart failure with preserved ejection fraction.

Authors:  Mouhamed Nashawi; Omar Sheikh; Ayman Battisha; Mahnoor Mir; Robert Chilton
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

6.  Effects of different exercise modalities on cardiac dysfunction in heart failure with preserved ejection fraction.

Authors:  David Bode; Natale P L Rolim; Tim Guthof; Niklas Hegemann; Paulina Wakula; Uwe Primessnig; Anne Marie Ormbostad Berre; Volker Adams; Ulrik Wisløff; Burkert M Pieske; Frank R Heinzel; Felix Hohendanner
Journal:  ESC Heart Fail       Date:  2021-03-25

Review 7.  Heart Failure With Preserved Ejection Fraction and Adipose Tissue: A Story of Two Tales.

Authors:  Albin Oh; Ross Okazaki; Flora Sam; Maria Valero-Muñoz
Journal:  Front Cardiovasc Med       Date:  2019-08-02

8.  ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction.

Authors:  Antje Schauer; Runa Draskowski; Anett Jannasch; Virginia Kirchhoff; Keita Goto; Anita Männel; Peggy Barthel; Antje Augstein; Ephraim Winzer; Malte Tugtekin; Siegfried Labeit; Axel Linke; Volker Adams
Journal:  ESC Heart Fail       Date:  2020-07-25

Review 9.  Unveiling the role of exercise training in targeting the inflammatory paradigm of heart failure with preserved ejection fraction: a narrative review.

Authors:  Eliane Jaconiano; Daniel Moreira-Gonçalves
Journal:  Heart Fail Rev       Date:  2021-07-10       Impact factor: 4.214

Review 10.  Skeletal muscle (dys)function in heart failure with preserved ejection fraction.

Authors:  Eng Leng Saw; Swetha Ramachandran; Maria Valero-Muñoz; Flora Sam
Journal:  Curr Opin Cardiol       Date:  2021-03-01       Impact factor: 2.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.